Ariad Pharmaceuticals After Hours

We collected information about Ariad Pharmaceuticals After Hours for you. Follow the liks to find out everything about Ariad Pharmaceuticals After Hours.


ARIAD Pharmaceuticals (ARIA) Drop in After Hours After ...

    https://www.streetinsider.com/Corporate+News/ARIAD+Pharmaceuticals+%28ARIA%29+Drop+in+After+Hours+After+Update+on+Business+Outlook/4833253.html
    Shares of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) are getting smoked in after hours...down over 18% after the company issued the following business outlook update.

ARIA Stock Forecast, Price & News (Ariad Pharmaceuticals)

    https://www.marketbeat.com/stocks/NASDAQ/ARIA/
    Ariad Pharmaceuticals Inc (NASDAQ:ARIA) posted its quarterly earnings data on Thursday, July, 28th. The pharmaceutical company reported $0.59 EPS for the quarter, beating the Zacks' consensus estimate of ($0.11) by $0.70. The pharmaceutical company had revenue of $65.30 million for the quarter, compared to analyst estimates of $60.64 million.

Takeda is buying Ariad Pharmaceuticals in a $5.2 billion …

    https://finance.yahoo.com/news/takeda-buying-ariad-pharmaceuticals-5-133410860.html
    The Japanese pharmaceutical company Takeda is buying the Cambridge, Massachussets-based Ariad Pharmaceuticals for $24 a share. The deal, valued at about $5.2 billion, is expected to close in February.

ARIA Stock Quote - ARIAD Pharmaceuticals, Inc. Stock Price ...

    https://thestockmarketwatch.com/stock/?stock=ARIA
    ARIAD is a Cambridge, Massachusetts-based biotechnology company focused on cancer. We are a cohesive team of talented people from diverse backgrounds with a shared vision: We seek to transform the lives of patients with breakthrough cancer medicines.

Takeda Completes Acquisition of ARIAD …

    https://www.takeda.com/newsroom/newsreleases/2017/Takeda-Completes-Acquisition-of-ARIAD-Pharmaceuticals-Inc/
    Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) (“ARIAD”) for $24.00 per share in cash. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals. The addition of ARIAD’s innovative targeted therapies and research and …

Ariad Pharmaceuticals, Inc. (ARIA): A few huge blocks in ...

    https://investorshub.advfn.com/boards/read_msg.aspx?message_id=125510682
    Ariad Pharmaceuticals, Inc. ARIA Stock Message Board: A few huge blocks in after hours (ie.

Tuesday's after-hours trading - Jan. 4, 2000

    https://money.cnn.com/2000/01/04/markets/ecn/
    Tuesday s after-hours trading. January 4, 2000: 8:43 p.m. ET. Ariad Pharmaceuticals sells stake, leads the charge after hours. NEW YORK (CNNfn) - After-hours traders stuck with the smaller stocks...

Ariad Pharmaceuticals Raises Cancer Drug Price For The …

    https://finance.yahoo.com/news/ariad-pharmaceuticals-raises-cancer-drug-184109762.html
    Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year. Read full article. ... The company released a discouraging business update after market hours on Friday, and its stock ...

ARIAD Pharmaceuticals - Wikipedia

    https://en.wikipedia.org/wiki/ARIAD_Pharmaceuticals
    ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients. ARIAD’s most prominent drug discoveries include Iclusig, …

Takeda grabs Ariad, expands oncology portfolio in $5.2B ...

    https://endpts.com/takeda-grabs-ariad-expands-oncology-portfolio-in-5-2b-buyout/
    Takeda has taken the next step in its global restructuring, bagging Ariad Pharmaceuticals for $5.2 billion and paying a whopping 74% premium for its stock. The deal gives Japan’s Takeda a bigger ...

Searching for Ariad Pharmaceuticals After Hours?

You can just click the links above. The info is collected for you.

Related Hours Info